<code id='42452F13C0'></code><style id='42452F13C0'></style>
    • <acronym id='42452F13C0'></acronym>
      <center id='42452F13C0'><center id='42452F13C0'><tfoot id='42452F13C0'></tfoot></center><abbr id='42452F13C0'><dir id='42452F13C0'><tfoot id='42452F13C0'></tfoot><noframes id='42452F13C0'>

    • <optgroup id='42452F13C0'><strike id='42452F13C0'><sup id='42452F13C0'></sup></strike><code id='42452F13C0'></code></optgroup>
        1. <b id='42452F13C0'><label id='42452F13C0'><select id='42452F13C0'><dt id='42452F13C0'><span id='42452F13C0'></span></dt></select></label></b><u id='42452F13C0'></u>
          <i id='42452F13C0'><strike id='42452F13C0'><tt id='42452F13C0'><pre id='42452F13C0'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:76131
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Orchard's therapy for neuron disease in children wins FDA approval
          Orchard's therapy for neuron disease in children wins FDA approval

          AdobeTheFoodandDrugAdministrationonMondayapprovedagenetherapyformetachromaticleukodystrophy,adevasta

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

          2:51Inthisundatedfilephoto,theUSCapitolbuildingisshowninWashington,D.C.STOCKIMAGE/GettyImagesLooking